Mallal SA - Search Results

1

A Rapid Allele-Specific Assay for HLA-A*32:01 to Identify Patients at Risk for Vancomycin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms.

Rwandamuriye FX, Chopra A, Konvinse KC, Choo L, Trubiano JA, Shaffer CM, Watson M, Mallal SA, Phillips EJ. Rwandamuriye FX, et al. Among authors: mallal sa. J Mol Diagn. 2019 Sep;21(5):782-789. doi: 10.1016/j.jmoldx.2019.04.006. Epub 2019 May 31. J Mol Diagn. 2019. PMID: 31158526 Free PMC article.

2

Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant.

Martin AM, Nolan D, Gaudieri S, Almeida CA, Nolan R, James I, Carvalho F, Phillips E, Christiansen FT, Purcell AW, McCluskey J, Mallal S. Martin AM, et al. Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4180-5. doi: 10.1073/pnas.0307067101. Epub 2004 Mar 15. Proc Natl Acad Sci U S A. 2004. PMID: 15024131 Free PMC article.

3

Pharmacogenetics of antiretroviral therapy: genetic variation of response and toxicity.

Martin AM, Nolan D, Gaudieri S, Phillips E, Mallal S. Martin AM, et al. Pharmacogenomics. 2004 Sep;5(6):643-55. doi: 10.1517/14622416.5.6.643. Pharmacogenomics. 2004. PMID: 15335286 Review.

4

Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts.

Martin AM, Nolan D, James I, Cameron P, Keller J, Moore C, Phillips E, Christiansen FT, Mallal S. Martin AM, et al. AIDS. 2005 Jan 3;19(1):97-9. doi: 10.1097/00002030-200501030-00014. AIDS. 2005. PMID: 15627041

5

HLA-B*5701 typing by sequence-specific amplification: validation and comparison with sequence-based typing.

Martin AM, Nolan D, Mallal S. Martin AM, et al. Tissue Antigens. 2005 Jun;65(6):571-4. doi: 10.1111/j.1399-0039.2005.00401.x. Tissue Antigens. 2005. PMID: 15896207

6

Clinical and immunogenetic correlates of abacavir hypersensitivity.

Phillips EJ, Wong GA, Kaul R, Shahabi K, Nolan DA, Knowles SR, Martin AM, Mallal SA, Shear NH. Phillips EJ, et al. Among authors: mallal sa. AIDS. 2005 Jun 10;19(9):979-81. doi: 10.1097/01.aids.0000171414.99409.fb. AIDS. 2005. PMID: 15905681

7

Efavirenz and CYP2B6 polymorphism: implications for drug toxicity and resistance.

Nolan D, Phillips E, Mallal S. Nolan D, et al. Clin Infect Dis. 2006 Feb 1;42(3):408-10. doi: 10.1086/499369. Epub 2005 Dec 27. Clin Infect Dis. 2006. PMID: 16392090 No abstract available.

8

A sensitive and rapid alternative to HLA typing as a genetic screening test for abacavir hypersensitivity syndrome.

Martin AM, Krueger R, Almeida CA, Nolan D, Phillips E, Mallal S. Martin AM, et al. Pharmacogenet Genomics. 2006 May;16(5):353-7. doi: 10.1097/01.fpc.0000197468.16126.cd. Pharmacogenet Genomics. 2006. PMID: 16609367

9

HLA-B*5701 screening for susceptibility to abacavir hypersensitivity.

Lucas A, Nolan D, Mallal S. Lucas A, et al. J Antimicrob Chemother. 2007 Apr;59(4):591-3. doi: 10.1093/jac/dkl557. Epub 2007 Feb 22. J Antimicrob Chemother. 2007. PMID: 17317695

10

Immune responses to abacavir in antigen-presenting cells from hypersensitive patients.

Martin AM, Almeida CA, Cameron P, Purcell AW, Nolan D, James I, McCluskey J, Phillips E, Landay A, Mallal S. Martin AM, et al. AIDS. 2007 Jun 19;21(10):1233-44. doi: 10.1097/QAD.0b013e3280119579. AIDS. 2007. PMID: 17545699

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

293 results

Search Page

Filters